Navigation Links
Sharps Compliance Corp. Announces New Senior Vice President of Sales and Marketing
Date:12/26/2007

HOUSTON, Dec. 26 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), leading providers of cost-effective disposal solutions for small quantity generators of medical waste, announced the promotion of Claude A. Dance to the position of Senior Vice President of Sales and Marketing, effective immediately. Mr. Dance, who joined the Company in August of 2007 as the Vice President of Sales - Emerging Markets, will be responsible for national, regional and inside sales efforts, as well as marketing and customer service functions.

Mr. Dance comes to Sharps from Capital Returns Inc., a leading reverse logistics company, where he served in various key roles including Senior Vice President of Sales and Marketing. Prior to Capital Returns, Mr. Dance served in various sales and management roles with Pharmerica, a division of AmerisourceBergen, Cardinal Health and Wyeth Pharmaceuticals. Mr. Dance graduated in 1981 with a BA in Marketing and earned an MA in 1983, both from Northwestern State University.

Dr. Burton J. Kunik, the Company's Chairman, Chief Executive Officer and President commented, "As a rapidly growing company, our organization and infrastructure continues to evolve as necessary in order to address the significant sales opportunities available to us. We have been very impressed with Claude's abilities and believe he will perform very well in his new leadership role. His management experience, combined with his ability to close large deals, is critical strengths as we pursue the many emerging market opportunities we have targeted."

David C. Mayfield, the Company's prior Senior Vice President of Sales and Marketing has accepted the position of Vice President of Pharmaceutical Sales and Reimbursement.

Kunik added, "David has made significant progress in the area of insurance reimbursement that we believe could lead to greater awareness about the proper disposal of used syringes in t
'/>"/>

SOURCE Sharps Compliance Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sharps Compliance Corp. Announces First Quarter Fiscal Year 2008 Conference Call and Webcast
2. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
3. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities
6. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
7. American Stock Exchange Accepts Encisions Plan to Regain Compliance
8. Critical HCCA Web/Audio Conference Will Review Office of Inspector General Compliance Concerns Outlined in FY 2008 Work Plan
9. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
10. Vendormate VISION 4.0(TM) Streamlines Healthcare Security and Compliance Efforts
11. Canada leads the way in contraceptive compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...RUZ, CA--New connections begin to form between bra... task, according to a study published this week in... California, Santa Cruz, the study involved detail...e place in the brain during motor learning. , Th... reach through a slot to get a seed. They observed...
(Date:11/29/2009)...s unaware the sleep disorder boosts urine producti...althDay News) -- People who wake up during the nig...ogical problem. Sleep apnea, a breathing-related s...y suggests that nighttime urination, or nocturia, ...ructive sleep apnea, a disorder in which soft tiss...
(Date:11/28/2009)..., CHICAGO, Nov. 28 Get ready for...e in the clinical routine when Siemens introdu...sembly and Annual Meeting of the Radiological Soci...cember 3 at McCormick Place (Booth #825, East Buil...syngo. via , Siemens, new imaging software fo...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/ -..."), a supplier of precision technology products an...nnual meeting of the Company,s shareholders has be... and location of the meeting will be announced in ...received a requisition notice from Stephen Bershad...
(Date:11/27/2009)...SAN FRANCISCO, Nov. 27 T... that Blair Lambert, CFO/COO, will present at the ...ld at the May Fair Hotel in London, England, on We..., To listen to a live broadcast of The Gymboree Co... log on to www.gymboree.com, click on "Our Company...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...f investigators led by St. Jude Children’s Researc...treatment of the childhood brain cancer medullobla...urvival of children with this disease. The t... and raised the rate of survival among the 48 high...
People who have a low response to alcohol or the so called ability to
...edicine as a specialty in New Zealand may no longe...ecommendation by the Medical Council comes into fo...opportunity of working with breast physicians unde... are unable to seek employment in breast clinics. ...
... proposal for prevention of chikungunya and dengue...rectorate of Public Health//. Aedes aegypti, m...causing virus and dengue causing virus. Hence, the...e will be examined. According to P. Padmanabha...
...D--A dart-like molecule that sticks to proteins in...wth of blood vessels, according to researchers at... Clinic Cole Eye Institute. //Uncontrolled blood v...r 65 in the United States. Robert Salomon and...
... inactivity, depression and falls all increase ris...rgeting falls may be a particularly effective way ...ding to a new study. Fall-prevention efforts ...ers led by Vicki Freedman, Ph.D., a professor at t...
Other Medicine News:Health News:Improved Treatment Raises Medulloblastoma Survival Rate 2Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Preventing Falls May Be Key to Avoiding Disability in Elderly 2
(Date:11/25/2009)... , EXTON, Pa., Nov. 25 BioTren...aunchTrends(TM) : Stelara report, the first i... tracking the launch of Centocor Ortho-Biotech,s S...months of availability. Each wave of the report p...rmatologists and qualitative information from a su...
(Date:11/25/2009)... , BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -...ding the development of antithrombotic aptamers wi...zo, PhD, CEO and President, will be presenting at ...ce at the New York Palace Hotel in New York City. ...(EST) on Tuesday, December 1 and will include an o...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewswire...cturer of direct digital Radiography ( ddR ) syste...acquired by a private Swiss Investor with a long t...g brand. The acquisition included all assets and i...entory. After 25 years of success and growth Swiss...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Obesity Contributes to Rapid Cartilage Loss 51575 1Obesity Contributes to Rapid Cartilage Loss 51575 2Obesity Contributes to Rapid Cartilage Loss 51575 3Obesity Contributes to Rapid Cartilage Loss 51575 4Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 1Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 2Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 3Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 4Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2
...Shows ADHD Patch Provides Tolerable and Effective ... SHP, Nasdaq:,SHPGY, TSX: SHQ), the global special...from a 12-month study of DAYTRANA(TM) (methylpheni...peractivity Disorder (ADHD),patch, demonstrated th...,and symptom control improvement in children aged ...
...umor Activity of NKTR-102 Associated With Increase... Active Metabolite of Irinotecan, SAN FRANCISCO, ...ented positive preclinical data today on its propr... at the AACR-NCI-EORTC,International Conference in...lighted the anti-tumor activity and unique pharmac...
Other Medicine Technology:Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 2NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 3NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 4NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 5
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: